ARTICLE | Company News
Clarient sales and marketing update
December 13, 2010 8:00 AM UTC
Clarient launched Mammostrat test in the U.S. to quantify the likelihood of recurrence of breast cancer following surgery and initial treatment. The prognostic test uses five biomarkers which are anal...